The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
Tandem Meetings 2023 | Association of cytopenia with survival in patients with B-cell lymphoma treated with CAR-T therapy
Nausheen Ahmed, MD, University of Kansas Medical Center, Westwood, KS, comments on the association between cytopenia at day 90 and survival in patients with B-cell malignancies treated with CAR-T therapy, highlighting potential strategies to manage this side effect. This interview took place at the 2023 Transplantation & Cellular Therapy Meetings of ASTCT™ and CIBMTR® held in Orlando, FL.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
BMS: Advisory Board; KUMC – Kite Pharma: Research Funding
